Additional Capital Will Help Fund Development of PAX-101 TARRYTOWN, NY, Feb. 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms, today announced that… Read More..

LAS VEGAS, NV / ACCESSWIRE / January 31, 2023 / SKYX Platforms Corp.(NASDAQ:SKYX) (d/b/a "Sky Technologies") SKYX a highly disruptive platform technology company with more than 60 issued and pending patents globally with a mission to make homes and buildings become safe and smart as the new standard, today announced… Read More..

RESEARCH TRIANGLE PARK, N.C., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the Company will host an Investor Day on… Read More..